Psammiad Therapeutics, Inc.
Biotechnology company · Denver, Colorado, United States
Psammiad Therapeutics, Inc. is a biotechnology company headquartered in Denver, Colorado, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $2.2 million sold in a notice filed in 2022.
Psammiad Therapeutics at a glance
What does Psammiad Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.2 million sold (2022).
Frequently asked questions about Psammiad Therapeutics
Where is Psammiad Therapeutics headquartered?
Psammiad Therapeutics, Inc. is headquartered in Denver, Colorado, United States.
What does Psammiad Therapeutics do?
Psammiad Therapeutics, Inc. is a biotechnology company.
When was Psammiad Therapeutics founded?
The earliest incorporation on record for Psammiad Therapeutics, Inc. is in 2022, according to public company registers.
Similar companies
- Vitro Biopharma, Inc.Denver, Colorado, United States
- RheumaGen, Inc.Denver, Colorado, United States
- BioCollective, LLCDenver, Colorado, United States
- BioMedInnovations LLCDenver, North Carolina, United States
- Cerecin Inc.Denver, Colorado, United States
- Cascade Biocatalysts, Inc.Denver, Colorado, United States
- Op-T-Mune, IncDenver, Colorado, United States
- Rock Immune, Inc.Denver, Colorado, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences